FDA Approves First Generic Methimazole for Treating Hyperthyroidism in Cats

U.S. Food and Drug Administration sent this bulletin at 07/09/2024 10:59 AM EDT

If your email program has trouble displaying this email, view as a webpage.
US Food and Drug Administration

FDA Approves First Generic Methimazole for Treating Hyperthyroidism in Cats

The U.S. Food and Drug Administration has approved Felanorm, the first generic methimazole oral solution for the treatment of hyperthyroidism in cats.

Felanorm contains the same active ingredient (methimazole) as the approved brand name drug product, Felimazole Coated Tablets, which were first approved on May 27, 2009. In addition, the FDA determined that Felanorm contains no inactive ingredients that may significantly affect the bioavailability of the active ingredient.

Read More Button


You are subscribed to updates from FDA's Center for Veterinary Medicine.